Figure 1.
(A) The percent of original weight of NSG mice that was lost/gained after administration of PTLD tumor cells before death. 5/7 mice had a significant weight loss, while two stayed relatively the same. (B) Survival curve for the 7 NSG mice injected with PTLD 13271. Median survival time (MST) = 60 days. (C) Representative gross pathology from the first passage of PTLD 13271 into NSG demonstrates severe organomegaly compared to normal controls. (D) Survival curve for the 19 NSG mice injected with CML 14736. 13/19 mice (68%) developed swine CML with a MST = 190 days. Notch marks represent mice that died but did not have swine CML.